CME Group (CME) Aktienübersicht
Die CME Group Inc. betreibt zusammen mit ihren Tochtergesellschaften weltweit Kontraktmärkte für den Handel mit Futures und Optionen auf Futures-Kontrakte. Mehr Details
| Schneeflocken-Punktzahl | |
|---|---|
| Bewertung | 4/6 |
| Künftiges Wachstum | 1/6 |
| Vergangene Leistung | 4/6 |
| Finanzielle Gesundheit | 6/6 |
| Dividenden | 4/6 |
Belohnungen
Risikoanalyse
CME Community Fair Values
Create NarrativeSee what 86 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
CME Group Inc. Wettbewerber
Preisentwicklung & Leistung
| Historische Aktienkurse | |
|---|---|
| Aktueller Aktienkurs | US$231.68 |
| 52-Wochen-Hoch | US$329.16 |
| 52-Wochen-Tief | US$231.30 |
| Beta | 0.24 |
| 1 Monat Veränderung | -18.00% |
| 3 Monate Veränderung | -21.14% |
| 1 Jahr Veränderung | -15.08% |
| 3 Jahre Veränderung | 26.35% |
| 5 Jahre Veränderung | 8.16% |
| Veränderung seit IPO | 2,600.23% |
Aktuelle Nachrichten und Updates
Analyseartikel • Jun 18
CME Group (CME) Stock Could Be 18% Undervalued After CEO Succession News
CME Group (CME) stock is in focus after the company confirmed a leadership transition that will see long time Chairman and CEO Terry Duffy move to Executive Chairman while President and CFO Lynne Fitzpatrick becomes CEO in 2027. See our latest analysis for CME Group. The leadership announcement landed against a weaker backdrop for CME Group stock, with the share price down 3.46% over the past day and 17.23% over the past 30 days, while the 5 year total shareholder return of 45.07% still...Seeking Alpha • Jun 16
CME: An Extreme Session Per Decade Has Become One Per Month
Summary CME Group benefits from heightened volatility and record derivatives volumes, driven by regime shifts in Fed policy and persistent macro uncertainty. Recent years show a structural increase in extreme trading sessions, with open interest and leveraged basis trades reaching unprecedented levels. I assign a Buy rating to CME, as its toll-collecting model thrives amid disagreement over rates and ongoing funding guarantees from the Fed. Normalization poses the main risk, but even in that scenario, CME offers a 4.2% dividend yield and trades near 23x earnings. Read the full article on Seeking AlphaRecent updates
Analyseartikel • Jun 18
CME Group (CME) Stock Could Be 18% Undervalued After CEO Succession News
CME Group (CME) stock is in focus after the company confirmed a leadership transition that will see long time Chairman and CEO Terry Duffy move to Executive Chairman while President and CFO Lynne Fitzpatrick becomes CEO in 2027. See our latest analysis for CME Group. The leadership announcement landed against a weaker backdrop for CME Group stock, with the share price down 3.46% over the past day and 17.23% over the past 30 days, while the 5 year total shareholder return of 45.07% still...Seeking Alpha • Jun 16
CME: An Extreme Session Per Decade Has Become One Per Month
Summary CME Group benefits from heightened volatility and record derivatives volumes, driven by regime shifts in Fed policy and persistent macro uncertainty. Recent years show a structural increase in extreme trading sessions, with open interest and leveraged basis trades reaching unprecedented levels. I assign a Buy rating to CME, as its toll-collecting model thrives amid disagreement over rates and ongoing funding guarantees from the Fed. Normalization poses the main risk, but even in that scenario, CME offers a 4.2% dividend yield and trades near 23x earnings. Read the full article on Seeking Alpha
Narrativ-Update • Jun 05
CME: Crypto And AI Futures Expansion Will Shape Future Earnings Power
Analysts have trimmed their average price target for CME Group to about $306.47. This reflects concerns that revenue momentum could soften as geopolitical volatility eases and that fresh competition in bitcoin perpetual futures may weigh on exchange valuations, even as several firms still see the competitive risk as manageable.Narrativ-Update • May 15
CME: Mixed Street Views And New Markets Will Shape Future Earnings Power
Narrative Update on CME Group The analyst price target for CME Group has been trimmed by about $2, reflecting updated views on slightly softer revenue growth and a modestly lower future P/E multiple. At the same time, some analysts highlight areas of support such as commodities volumes as well as agriculture and prediction markets.Narrativ-Update • Apr 27
CME: Volatile Street Views And New Futures Will Shape Trading Mix
Analysts have nudged their fair value estimate for CME Group down to $308.20 from $311.67, reflecting slightly softer revenue growth assumptions and a higher discount rate, partly balanced by a higher projected profit margin and a modestly lower future P/E, in line with the mix of recent price target trims and increases across the Street. Analyst Commentary Recent Street research on CME Group has been active on both sides, with several firms adjusting price targets and ratings in different directions.Narrativ-Update • Apr 11
CME: Volatility And New Contracts Will Shape Rare Earths And Crypto Volumes
The updated analyst price target for CME Group has moved higher by about $5 to $311.67. This change reflects analysts' use of a slightly lower discount rate, a modestly higher assumed revenue growth rate, and a marginally higher future P/E multiple, even as they factor in a small trim to projected profit margins.Narrativ-Update • Mar 26
CME: Volatility And New Contracts Will Shape Rare Earths And Volume Mix
Analysts have made a modest upward adjustment to the CME Group fair value estimate to about $307 from roughly $305, reflecting slightly revised assumptions for discount rate, revenue growth, profit margin, and future P/E following a mix of recent rating changes and price target tweaks across the Street. Analyst Commentary Recent research on CME Group reflects a mixed but generally balanced backdrop, with several firms adjusting ratings and price targets in different directions.Narrativ-Update • Mar 11
CME: Volatility And New Contracts Will Shape Rare Earths And Clearing Outlook
Our analyst price target for CME Group has moved modestly higher to $305.21 from $299.29, as analysts factor in slightly stronger modeled revenue growth and profitability. This is partially offset by a more conservative future P/E assumption and mixed views on volume drivers across product lines.Narrativ-Update • Feb 25
CME: Volatility And New Contracts Will Shape Futures And Clearing Outlook
The analyst price target for CME Group edges higher to $232, with recent updates reflecting analysts' focus on firmer commodities volumes, as well as a more expense conscious outlook in their refreshed earnings models. Analyst Commentary Recent Street research around CME Group reflects a mix of optimism on volumes and earnings power, alongside caution on valuation and the cost base.Narrativ-Update • Feb 10
CME: Volatility And Prediction Markets Will Guide Futures And Clearing Expansion Outlook
The updated analyst price target for CME Group edges higher to about US$297 from roughly US$290, reflecting analysts' use of a slightly lower discount rate, a modestly higher assumed revenue growth rate, and a similar future P/E multiple despite a slightly lower profit margin input. Analyst Commentary Street research on CME Group in recent sessions centers on a cluster of revised price targets and at least one rating change, with several bullish analysts lifting their targets by varying dollar amounts and one major bank fine tuning its view in both directions over a short time frame.Narrativ-Update • Jan 27
CME: Volatility And Prediction Markets Will Shape Futures Activity Outlook
The analyst price target for CME Group is now US$290.40, a move of about US$2 from the prior US$288.33, as analysts factor in slightly different assumptions for fair value, discount rate, revenue growth, profit margins, and future P/E following mixed recent research that includes both a modest target cut and an upgrade linked to a tilt toward volatility. Analyst Commentary Recent research on CME Group reflects a mix of optimism and caution, with one firm trimming its price target slightly and another upgrading the stock on what it sees as a better setup for volatility related trading activity.Narrativ-Update • Jan 12
CME: Fee Moat And Prediction Markets Will Shape Futures Activity Outlook
Narrative Update: CME Group CME Group's fair value estimate has edged up by about $1 to roughly $288 per share, as analysts cite the company's strong futures and options moat, a higher price target range of up to $314, and interest in its role within prediction markets as key supports for the updated outlook. Analyst Commentary Recent Street research has been generally constructive on CME Group, with several bullish analysts adjusting their price targets higher and highlighting the company's futures and options franchise as a key support for valuation.Narrativ-Update • Dec 27
CME: Fee Resilience And Prediction Markets Will Balance Lower Volatility Risks
Analysts have nudged their average price target on CME Group modestly higher, to approximately $287 from about $286, citing the company’s resilient fee-based revenue mix, strong competitive moat in futures and options, and supportive demand signals from prediction market partnerships despite some conflicting views on near term volume volatility. Analyst Commentary Recent Street research presents a mixed but generally constructive view on CME Group, with upward moves in price targets tempered by concerns around volume sensitivity and valuation risk if volatility normalizes.Narrativ-Update • Dec 13
CME: Fee Resilience And New Prediction Markets Will Help Navigate Volatility
Analysts have raised their fair value estimate for CME Group by about $1 to roughly $286 per share, citing the company’s resilient clearing and transaction fee driven revenue base, modestly higher long term growth expectations, and a reinforced competitive moat highlighted in recent target revisions across the Street. Analyst Commentary Street research on CME Group reflects a wide range of views on valuation and execution, with recent target changes clustering around expectations for resilient fee income but diverging on the sustainability of growth and the impact of lower volatility.Narrativ-Update • Nov 16
CME: Revenue Resilience And New Ventures Will Balance Volatility Risks Ahead
The average analyst price target for CME Group was raised by approximately $3 to $285, as analysts point to the firm's resilient revenue streams and strong market position amid continued macroeconomic uncertainty. Analyst Commentary Recent analyst activity reflects a mix of optimism and caution regarding CME Group's performance and outlook, particularly as the firm navigates shifting macroeconomic and market conditions.Seeking Alpha • Apr 27
CME: More Market Volatility Equals More Demands - Initiating With Strong Buy
Summary Initiating a 'Strong Buy' rating for CME with a fair value of $301 per share due to increased demand for hedging amid economic uncertainty and market volatility. CME's diverse product offerings and strong trading volume growth, particularly in interest rate options/futures, equity, FX, energy, and commodities, support its robust business model. CME's high operating margin, capex-light business model, and strategic use of Google Cloud enhance profitability and operational efficiency. Key risks include potential pushback on market data price increases and competition from FMX Futures Exchange in the US treasury market. Read the full article on Seeking AlphaSeeking Alpha • Mar 27
CME Group At A New All-Time High - Valuation Concerns Justified?
Summary CME shares have delivered market-beating returns over the past two years, prompting the question of whether it's time to lock in profits. In this update, I discuss whether the rally appears sustainable against the backdrop of the 2024 results published in mid-February. The analysis focuses on average contract volumes and rates, signs of potential underinvestment given the surprisingly strong free cash flow, and includes an update on debt and leverage. I explain why I do not intend to sell my CME stock position despite the elevated valuation, and why I am not even considering a covered call strategy at this time. Read the full article on Seeking AlphaAktionärsrenditen
| CME | US Capital Markets | US Markt | |
|---|---|---|---|
| 7D | -6.0% | -4.2% | -2.5% |
| 1Y | -15.1% | 4.1% | 20.1% |
Rendite im Vergleich zur Industrie: CME unter dem Niveau der Branche US Capital Markets , die im vergangenen Jahr eine Rendite von 4.1% erzielte.
Rendite vs. Markt: CME hinter dem Markt US zurück, der im vergangenen Jahr eine Rendite von 20.1 erzielte.
Preisvolatilität
| CME volatility | |
|---|---|
| CME Average Weekly Movement | 4.1% |
| Capital Markets Industry Average Movement | 3.8% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stabiler Aktienkurs: CME hatte in den letzten 3 Monaten im Vergleich zum US -Markt keine signifikante Preisvolatilität.
Volatilität im Zeitverlauf: CMEDie wöchentliche Volatilität (4%) ist im vergangenen Jahr stabil geblieben.
Über das Unternehmen
| Gegründet | Mitarbeiter | CEO | Website |
|---|---|---|---|
| 1898 | 3,875 | Terry Duffy | www.cmegroup.com |
Die CME Group Inc. betreibt zusammen mit ihren Tochtergesellschaften weltweit Kontraktmärkte für den Handel mit Futures und Optionen auf Futures-Kontrakte. Das Unternehmen bietet Futures und Optionen auf Zinssätze, Aktienindizes und Devisen, Agrar-, Energie- und Metallrohstoffe sowie Dienstleistungen für den Handel mit festverzinslichen Wertpapieren und Devisen an. Das Unternehmen erbringt Clearinghaus-Dienstleistungen, einschließlich Clearing, Abrechnung und Garantie von Futures- und Optionskontrakten, sowie geclearte Swap-Produkte, die über seine Börsen gehandelt werden.
CME Group Inc.'s Grundlagenzusammenfassung
| CME grundlegende Statistiken | |
|---|---|
| Marktanteil | US$83.95b |
| Gewinn(TTM) | US$4.24b |
| Umsatz(TTM) | US$6.74b |
19.8x
Kurs-Gewinn-Verhältnis 12.4x
Kurs-Umsatz-VerhältnisIst CME zu teuer?
Siehe Fair Value und BewertungsanalyseErträge & Einnahmen
| CME Gewinn- und Verlustrechnung (TTM) | |
|---|---|
| Einnahmen | US$6.74b |
| Kosten der Einnahmen | US$0 |
| Bruttogewinn | US$6.74b |
| Sonstige Ausgaben | US$2.50b |
| Gewinn | US$4.24b |
Zuletzt gemeldete Gewinne
Mar 31, 2026
Datum des nächsten Gewinnberichts
Jul 22, 2026
| Gewinn per Aktie (EPS) | 11.71 |
| Bruttomarge | 100.00% |
| Nettogewinnspanne | 62.95% |
| Schulden/Eigenkapital-Verhältnis | 12.9% |
Wie hat sich CME auf lange Sicht entwickelt?
Historische Performance und VergleicheDividenden
4.9%
Aktuelle Dividendenrendite43%
AusschüttungsquoteZahlt CME eine zuverlässige Dividende?
Siehe CME Dividendenhistorie und Benchmarks| CME Group Dividendentermine | |
|---|---|
| Ex-Dividenden Datum | Jun 09 2026 |
| Datum der Dividendenzahlung | Jun 25 2026 |
| Tage bis Ex-Dividende | 16 days |
| Tage bis zum Datum der Dividendenzahlung | 0 days |
Zahlt CME eine zuverlässige Dividende?
Siehe CME Dividendenhistorie und BenchmarksUnternehmensanalyse und Finanzdaten Status
| Daten | Zuletzt aktualisiert (UTC-Zeit) |
|---|---|
| Unternehmensanalyse | 2026/06/25 03:43 |
| Aktienkurs zum Tagesende | 2026/06/24 00:00 |
| Gewinne | 2026/03/31 |
| Jährliche Einnahmen | 2025/12/31 |
Datenquellen
Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.
| Paket | Daten | Zeitrahmen | Beispiel US-Quelle * |
|---|---|---|---|
| Finanzdaten des Unternehmens | 10 Jahre |
| |
| Konsensschätzungen der Analysten | +3 Jahre |
|
|
| Marktpreise | 30 Jahre |
| |
| Eigentümerschaft | 10 Jahre |
| |
| Verwaltung | 10 Jahre |
| |
| Wichtige Entwicklungen | 10 Jahre |
|
* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.
Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.
Analysemodell und Schneeflocke
Details des Analysemodells, das zur Erstellung dieses Berichts verwendet wurde, sind auf unserer GitHub-Seite verfügbar. Außerdem haben wir Leitfäden zur Nutzung unserer Berichte und Tutorials auf YouTube.
Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.
Metriken für Industrie und Sektor
Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.
Analysten-Quellen
CME Group Inc. wird von 32 Analysten beobachtet. 13 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.
| Analyst | Einrichtung |
|---|---|
| Stephen Biggar | Argus Research Company |
| Benjamin Budish | Barclays |
| Roger Freeman | Barclays |